SpeeDx, Nepean Hospital win funding for viral respiratory biomarker test
The test utilises newly patented InSignia technology. (Credit: Sara Eshleman/Wikimedia Commons.)
NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X